Consolidated Balance Sheet - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current Assets
Cash and cash equivalents	$ 111	$ 19
Total Current Assets	111	19
Total Assets	111	19
Current Liabilities
Account payable	165,466	165,466
Accrued liabilities	1,554,862	1,232,927
Convertible note payable, current	1,559,803	1,515,178
Derivative liabilities	2,298,820	2,191,745
Promissory notes payable, current		17,500
Related party payables	4,505	155
Total current liabilities	5,583,456	5,122,971
Capital lease liability, net
Total Liabilities	5,583,456	5,122,971
Commitments and contingencies
Stockholders’ Deficit:
Preferred stock - Series A, $0.00001 par value. 69,999,990 shares authorized; 10,000,0000 shares issued and outstanding as of December 31, 2020 and 2019, respectively	100	100
Preferred stock - Series D, $0.00001 par value. 1 share authorized; 1 and zero shares issued and outstanding as of December 31, 2020 and 2019, respectively
Preferred stock - Series E, $0.00001 par value. 50 shares authorized; 24 and 12 shares issued and outstanding as of December 31, 2020 and 2019, respectively
Common stock, $0.00001 par value. 11,000,000,000 shares authorized; 10,192,519,400 and 8,638,186,067 shares issued and outstanding as of December 31, 2020 and 2019, respectively	101,925	86,382
Additional paid In Capital	8,984,757	8,894,472
Accumulated deficit	(14,670,127)	(14,103,906)
Total Stockholders' Deficit	(5,583,345)	(5,122,952)
Total Liabilities and Stockholders' Deficit	$ 111	$ 19